Meda AB is a Sweden-based specialty pharmaceutical company. The Company is primarily engaged in sales, marketing and market-adapted product development, refraining from capital-intensive and high-risk early research. Meda's product flow comes from partnerships, licensing and acquisitions. The products are delivered from the Company’s manufacturing units in France, Germany and the United States, as well as from external manufacturing companies. Meda's product portfolio consists of over the counter (OTC) brands and specialist preparations. Its prioritized therapeutic areas are respiratory, cardiology, pain and inflammation, dermatology, and Central Nervous System (CNS). The Company has own sales and marketing organizations in more than 40 countries, and its primary markets are Europe and the United States.
Research Alerts:
Receive alerts on the latest reports on Meda AB
Subscribe to Research Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
